Baxter International Aktie

Baxter International für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 853815 / ISIN: US0718131099

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
26.04.2017 13:26:16

Baxter Raises Financial Outlook - Quick Facts

(RTTNews) - Baxter International Inc. (BAX) announced, for full-year 2017, based on the strong first quarter, the company now expects sales growth of approximately 1 to 2 percent on a reported basis or 2 to 3 percent on a constant currency basis, and earnings from continuing operations, before special items, of $2.20 to $2.28 per share for the full year. Adjusting for the impact of generic cyclophosphamide competition and selected strategic product exits, Baxter expects underlying constant currency sales growth of approximately 4 to 5 percent.

For the second quarter, the company expects flat sales growth on a reported basis, or approximately 2 percent on a constant currency basis. Adjusting for the impact of generic cyclophosphamide competition and selected strategic product exits, Baxter expects underlying constant currency sales growth of approximately 3 percent. The company expects earnings from continuing operations, before special items, of $0.55 to $0.57 per share.

Analysen zu Baxter International Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Baxter International Inc. 26,54 -1,03% Baxter International Inc.